Fundamentals of Population Pharmacokinetic Modelling : Modelling and Software.
about
Population pharmacokinetics analysis of olanzapine for Chinese psychotic patients based on clinical therapeutic drug monitoring data with assistance of meta-analysis.The present and future of withdrawal period calculations for milk in the European Union: focus on heterogeneous, nonmonotonic data.Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and DocumentationPragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery.Prediction of drug disposition on the basis of its chemical structure.Enhancing population pharmacokinetic modeling efficiency and quality using an integrated workflow.Mathematical modeling and simulation in animal health. Part I: Moving beyond pharmacokinetics.Mathematical modeling and simulation in animal health - Part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment.The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.Multi-scale Modeling in Clinical Oncology: Opportunities and Barriers to Success.Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension.Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.Using sensitivity equations for computing gradients of the FOCE and FOCEI approximations to the population likelihood.Abnormal olanzapine toxicokinetic profiles--population pharmacokinetic analysis.Population pharmacodynamic model for low molecular weight heparin nadroparin in morbidly obese and non-obese patients using anti-Xa levels as endpoint.Revolutionizing Therapeutic Drug Monitoring with the Use of Interstitial Fluid and Microneedles Technology.Population Pharmacokinetics of Mycophenolic Acid: An Update.Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact.Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination
P2860
Q31085591-7BA28178-22F6-4D0B-9541-4A6A6BEDB0D8Q31127244-F1029E1F-83C5-465D-8A2C-64FB57B8FD58Q36734132-AAF1A1BD-3FA4-4E5C-B33B-AB24B126D4DAQ36924737-CD4EA0FB-812E-4E2F-BDF2-CA4F65849E24Q38086778-AA9B435F-29BB-419F-830C-C903BCDCB76FQ38233301-9E44CDDE-277B-435E-AE4A-0F275ED4847DQ38642539-26B1ED81-C024-4C6D-AAB9-3C879DAECB68Q38810378-51C18E7A-8935-490E-8410-8977CA1F1927Q38837353-5F108CD5-89A3-49CA-9754-49FF70A66C18Q38888255-02984F85-92AD-4C87-974B-E571197F4D28Q39479847-90A75325-6B09-428B-81C3-8EF762E78A35Q40118820-8E6973FA-A40A-4FA0-BF51-EA0EFBA99350Q40674519-091AE315-0A89-413E-9833-3E44CA677A61Q44249533-9C73B38A-BB9F-460C-83BE-259AA8FE320AQ47431339-0CF3C48F-D581-46DB-87C2-48AE1D5184BBQ47580223-19846A4A-4A14-4633-BBFA-7501D8799928Q47871343-15E19839-C809-4818-96BE-5C49D53910EBQ49171317-AA9F16F2-9B85-41AE-8ADD-9B88396BE4EAQ57816952-2BFFC903-FA91-419A-8B4D-58A54F968561
P2860
Fundamentals of Population Pharmacokinetic Modelling : Modelling and Software.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Fundamentals of Population Pharmacokinetic Modelling : Modelling and Software.
@en
type
label
Fundamentals of Population Pharmacokinetic Modelling : Modelling and Software.
@en
prefLabel
Fundamentals of Population Pharmacokinetic Modelling : Modelling and Software.
@en
P2093
P2860
P356
P1476
Fundamentals of Population Pharmacokinetic Modelling : Modelling and Software.
@en
P2093
Catherine M T Sherwin
Mary H H Ensom
Michael G Spigarelli
Tony K L Kiang
P2860
P2888
P304
P356
10.1007/BF03261928
P577
2012-08-01T00:00:00Z
P6179
1017511584